Year: 2017
Type: article
Abstract: BACKGROUND: Randomised clinical trials are key to advancing medical knowledge and to enhancing patient care, but major barriers to their conduct exist. The present paper presents some of these barriers. METHODS: We performed systematic literature searches and internal European Clinical Research Infrastructure Network (ECRIN) communications during face-to-face meetings and telephone conferences from 2013 to 2017 within the context of the ECRIN Integrating Activity (ECRIN-IA) project. RESULTS: The following barriers to randomised clinical trials were identified: inadequate knowledge of clinical research and trial methodology; lack of funding; excessive monitoring; restrictive privacy law and lack of transparency; complex regulatory requirements; and inadequate infrastructures. There is a need for more pragmatic randomised clinical trials conducted with low risks of systematic and random errors, and multinational cooperation is essential. CONCLUSIONS: The present paper presents major barriers to randomised clinical trials. It also underlines the value of using a pan-European-distributed infrastructure to help investigators overcome barriers for multi-country trials in any disease area.
Source: Trials
Institutions: Copenhagen University Hospital, Rigshospitalet, Inserm, Orphanet, European Clinical Research Infrastructure Network, Mario Negri Institute for Pharmacological Research, European Organisation for Rare Diseases, Witten/Herdecke University, Lyon 1 Université, Université de Lyon, Hospices Civils de Lyon, Centre de Recherche en Nutrition Humaine Rhône-Alpes, Vienna General Hospital, Holbæk Sygehus
Language: English
Topic: Ethics in Clinical Research
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,790
OpenAlex ID: W2740724526